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Abstract
Published compact and extended models of the glucose-insulin physiologic control system
are compared, in order to understand why a specific functional form of the compact model
proved to be necessary for a satisfactory representation of acute perturbation experiments
such as the Intra Venous Glucose Tolerance Test (IVGTT). A spectrum of IVGTT’s of
virtual subjects ranging from normal to IFG to IGT to frank T2DM were simulated using an
extended model incorporating the population-of-controllers paradigm originally hypothe-
sized by Grodsky, and proven to be able to capture a wide array of experimental results
from heterogeneous perturbation procedures. The simulated IVGTT’s were then fitted with
the Single-Delay Model (SDM), a compact model with only six free parameters, previously
shown to be very effective in delivering precise estimates of insulin sensitivity and secretion
during an IVGTT. Comparison of the generating, extended-model parameter values with the
obtained compact model estimates shows that the functional form of the nonlinear insulin-
secretion term, empirically found to be necessary for the compact model to satisfactorily fit
clinical observations, captures the pancreatic reserve level of the simulated virtual patients.
This result supports the validity of the compact model as a meaningful analysis tool for the
clinical assessment of insulin sensitivity.
Introduction
Mathematical models for representing and simulating insulin/glucose metabolism, both in
normal conditions and under perturbation tests, have been developed and used since the
1960’s [1]. Their importance resides in the possibility to better understand the pathophysiology
and development of Type 2 Diabetes Mellitus (T2DM) and of its pre-conditions, such as
Impaired Glucose Tolerance (IGT) or Impaired Fasting Glucose (IFG). More extended models
are also used to simulate virtual patients in order to test control algorithms, (i.e. [2–6] and ref-
erences within) in situations where experimental procedures are very expensive or cannot be
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performed for ethical or practical reasons. Models can be more or less complex according to
how many sub-components of the entire metabolic system are simulated (glucagon, adrenalin,
Free Fatty Acids, etc.) and according to the level at which the relevant physiology is modelled
(e.g. whole-body or cellular). Comprehensive models of the glucose-insulin system [7, 8] allow
to simulate healthy subjects and T2DM patients for clinical research purposes, e.g. for testing
control algorithms in silico.
Two test procedures in general use for the estimation of insulin sensitivity are the Intra-
Venous Glucose Tolerance Test (IVGTT), which needs to be analyzed by means of a suitable
mathematical model [9–11]; and the Euglycemic Hyperinsulinemic Clamp (EHC) [12], con-
sidered the ‘gold standard’ for the assessment of insulin resistance, which yields a measure of
insulin sensitivity by direct averaging of the final glucose infusion rate. The standard IVGTT is
simpler to perform than the EHC, has no significant associated risks and, if appropriately
modelled, provides important information about the negative feedback regulation of glucose
and insulin in a specific subject. Efforts have been made therefore to develop better models for
the interpretation of the IVGTT experimental data set, exhibiting behaviour compatible with
physiology (for example bounded and positive solutions of the model, as for example glucose
predictions that never go to infinity or assume negative values) [13] and providing stable
(assuming similar magnitude among different subjects), precise estimates of the structural
model parameters [10]. Minimal models (minimal in the number of equations and in the
number of parameters to be estimated) have therefore been developed to estimate the insulin
sensitivity of a specific subject from a relatively non-invasive test procedure such the IVGTT.
The so-called “Minimal Model” (MM) [9], which is still the most widely used compact model
in the clinical setting, was demonstrated [11, 13] to suffer from a number of drawbacks,
among which poor parameter estimation, with very large parameter coefficients of variation,
translating into overall non-identifiability of the model parameters, including in particular the
SI index of insulin sensitivity. Moreover, the estimation procedure typically used, decoupling
the feedback and estimating separately the two glucose-insulin control arms, provides mislead-
ing results as is discussed in greater detail elsewhere [10]. An alternative model of the compact
model class, previously published by the present authors [10] and referred to as the Single
Delay Model (SDM), was demonstrated to have mathematically consistent solutions, admit-
ting the fasting state as its single equilibrium point and converging back to it from the per-
turbed state. This model was simultaneously fitted to glucose and insulin IVGTT observations
on a heterogeneous population composed of lean, overweight, obese and morbidily obese sub-
jects and was proven to outperform the MM over the whole range of conditions considered
[11]. An extension of the SDM was subsequently proposed [14], where in order to model the
fate of per os glucose, a gastrointestinal tract model was added to the plasma insulin and glu-
cose dynamic equations and the glucose rate of appearance was derived by describing the
absorption of glucose along a sequence of three gut compartments.
With the aim of interpreting a wide range of heterogeneous experimental results related to
pancreatic insulin secretion, an islet population model was proposed in 2010 [15], incorporat-
ing the original idea of Grodsky of a population of independent controllers, coupled only by
circulating glucose levels [16]. This model explains the effect of the islet response to varying
glucose concentrations by means of a simple second-order nonlinear model, of the same func-
tional form for all islets, with a random distribution of parameter values over the large number
of islets considered. The population of pancreatic β-cells, collected into Langerhans islets, can
be viewed therefore as a set of independent, similar, but not identical controllers (firing units)
with distributed functional parameters. The islet equations are coupled to a metabolism sub-
model to complete the description of the feed-back control of the glucose/insulin system
dynamics. This islet population model was shown to reproduce very closely a wide array of
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actually observed, diverse in vivo and in vitro experiments, including the pioneering work of
Grodsky, with the same set of working parameters [17]. While the model does not include any
dependency on the rate of change of glycemia, it is able to reproduce accurately the double
phase of insulin release during a prolonged glucose stimulus: a first phase of impulsive insulin
release, immediately upon glucose administration, and a second phase of more gradual release,
also linked with the potentiation effect of persistent hyperglycemia on the secretory units.
During the course of the development of the SDM in 2007 it was appreciated that, while the
inclusion of some model components was irrelevant to the quality of data fitting (e.g. the inclu-
sion of “glucose effectiveness” or an esplicit representation of the delay of insulin action on
glucose), other elements, such as the delay τ and the exponent γ, were indispensable, and
neglecting them led to the inability of the model to adequately fit the observations. Parameter
τ represents the delay with which the pancreas changes secondary insulin release in response
to varying glycemia, while the exponent γ represents the rapidity with which the insulin secre-
tion rate reaches its maximum value with increasing glycemia. It was proven in [10] that both
the delay τ and the exponent γ included into a nonlinear sigmoidal function were indeed nec-
essary to interpret data.
Now, a few years after the publication of the SDM model, a comprehensive model for insu-
lin secretion exists [15, 17], which is in fact able to explain mechanistically why a host of mor-
phologically diverse insulin secretion responses to glycemic perturbations occur. We can
therefore go back and attempt to understand why the nonlinearity γ was so essential in the
representation of insulin secretion within the compact SDM model: this is the aim of the pres-
ent work.
The reason why the islet population model is used as a comparison model is that it mirrors
the actual anatomic structure of the endocrine pancreas and, at the same time, is able to con-
vincingly reproduce observed insulin secretion patterns after many different types of glycemic
perturbations.
Starting from the extended and validated model [17], the following procedure is imple-
mented: a) a sample of IVGTT data sets is generated from the extended model portraying a
group of virtual patients with a range of insulin sensitivities; b) the generated IVGTTs are fitted
with the SDM compact model; c) a comparison is made between the set of generating extended
model parameter values and the set of estimated compact-model parameter values to clarify
their relationships.
Methods
Compact Model
The delay model used in the present work, henceforth Compact Model (see Fig 1), has been
shown to be able to represent well the glucose and insulin concentrations observed during an
Intra-Venous Glucose Tolerance Test (IVGTT) [10]. Using this model it is possible to estimate
the insulin sensitivity of a patient by fitting the patient’s IVGTT data, and this estimation is
precise, reproducible and robust [11]. This model has been shown to admit mathematically
consistent solutions with physiologically plausible parameter values [18].
Let G(t) and I(t) be, respectively, the plasma glucose concentration [mM] and the serum
insulin concentration [pM], while their distribution volumes are indicated, respectively, as VG
[L/kgBW] and VI [L/kgBW]. The differential equation representing variation of plasma glu-
cose concentration is:
dGðtÞ
dt
¼   kXGIIðtÞGðtÞ þ
Tgh
VG
; ð1Þ
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with initial conditions:
GðtÞ ¼ Gb 8t 2 ð  1; 0Þ; Gð0Þ ¼ Gb þ GD;
where GD ¼
Dg
VG
:
ð2Þ
The glucose basal concentration Gb [mM] is the glycemia level before the bolus injection,
while GΔ [mM] represents glycemia increase following the bolus. Dg [mmol/kgBW] is the
intravenous dose of glucose administered at time 0 during an IVGTT experiment. The equa-
tion representing the dynamics of plasma insulin concentration I [pM] is the following:
dIðtÞ
dt
¼   kXIIðtÞ þ
Tmaxig
VI
Gðt  tg Þ
G�
� �g
1þ
Gðt  tg Þ
G�
� �g ; ð3Þ
with initial condition:
Ið0Þ ¼ Ib þ IDGGD; ð4Þ
The novelty this model introduced is in the second term of (3), representing second-phase
insulin delivery from the β-cells. Its functional form is consistent with the hypothesis that insu-
lin production is limited, reaching a maximal rate of release Tmaxig =VI by way of a Michaelis-
Menten or a sigmoidal Hill dynamics according to whether the γ value is 1 or greater than 1
respectively. The constant values Tgh and Tmaxig can be directly computed from the steady state
conditions of Eqs (1) and (3) respectively. See the original references for more details [10, 11].
Fig 1. Schematic representation of the Compact Model. Glucose Plasma concentrations arise following an IntraVenous Glucose Dose. Input to
plasma Glucose compartment comes also from the liver which produces glucose by means of gluconeogenesis and glycogenolysis processes, while
elimination occurs by an independent (first order elimination rate) and dependent-insulin mechanism (second order tissue uptake). High plasma
glucose concentrations enhance insulin release in plasma, while insulin is cleared with a first order elimination rate.
https://doi.org/10.1371/journal.pone.0211331.g001
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Extended Model
The mathematical model of the glucose-insulin system presented in [17], henceforth Extended
Model, has been the first model of whole-body insulin secretion to provide a unified explana-
tion of an array of diverse clinical experimental procedures. In fact, the model is able to repro-
duce, with the same set of (meta)parameters: the low-frequency ultradian oscillations
appreciable in the insulinemic signal when a constant enteral feeding is administered to a
patient [19]; the entrainment of insulinemia to glycemia when a patient undergoes different
Intra-Venous (I.V.) glucose administration patterns with different frequencies [20]; high-fre-
quency insulinemia oscillations triggered by I.V. administration of very small amounts of glu-
cose [21]; reproduction of the glycemia and two-stage-insulinemia (first and second phase)
curves, upon simulated I.V. glucose administration during an IVGTT experiment. In this latter
case, moreover, the model is able to mimic the clinically observable glycemia and insulinemia
curves both for Normal Glucose Regulation (NGR) and for different pre-morbid and morbid
conditions, such as Impaired Fasting Glycemia (IFG), Impaired Glucose Tolerance (IGT),
IFG+IGT and Type 2 Diabetes Mellitus (T2DM).
While this model is extensively discussed elsewhere [17], we briefly summarize its features
in the following.
The basic paradigm of this model (see Fig 2) is that in the pancreas a multitude of similar,
but not identical, independent controllers react to the sensed plasma glucose, which acts as the
single “coupling” signal. While the qualitative behavior of the firing units is the same, each unit
reacts differently to glycemia, and these heterogeneous performances yield the characteristic
insulin responses to different stimuli. Note that the physiological identification of the firing
unit could be the β-cells scattered in the pancreatic Langerhans islet, or, by choosing a different
level of model granularity, subcellular granules, or, conversely, collections of synchronized β-
cells within the islets of Langerhans (for more details, see [17]).
Fig 2. Schematic representation of the Extended Model. The pancreas secretory units (circles) release at different times their packet of insulin Jn(t)
(depending, for the n-th controller, on the threshold Bn(t) and on the potentiation level Dn(t)) in such a way that at any given time a total quantity J(t)
(sum of the amounts Jn(t)) of insulin flows into the portal vein (Q1 compartment), then to the liver (Qi+1. . .QL compartments) and finally reaching the
plasma (compartment I), stimulating the uptake of glucose by tissues. Glycemia (G compartment), which is raised by glucose hepatic production k3,
stimulates the production of insulin, closing the loop.
https://doi.org/10.1371/journal.pone.0211331.g002
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A firing unit (unit n) releases at time t� its stored packet of insulin Jn(t�) [pmol/kgBW]
whenever circulating glycemia exceeds the current threshold value Bn(t�) [mM], thereupon
entering a (relative) refractory state, where further stimulation fails to elicit the release of new
hormone (the time-course of the threshold function Bn(t) is in general different for each unit
n); the refractory state of unit n is represented in the model by instantaneously increasing the
glycemia threshold of that unit to a high level Rn [mM] whence, over time, it exponentially
decreases towards its resting threshold value Gn [mM], Gn< Rn. As soon as the controller
fires, its threshold abruptly increases its value and the controller enters a refractory state. From
this moment onwards, the threshold value decreases exponentially. When the threshold Bn
reaches again values comparable with the current glycemia, the unit n is ready to release a new
packet again. The size of the packet of insulin itself depends on prevailing glycemias: in fact,
the well-known phenomenon of potentiation occurs, that is the ability of the pancreas to
respond with progressively increasing insulin amounts to identical glucose stimuli, when these
are repeated in close proximity over time [16, 22, 23]. The variation in size of the packet of
insulin (subject to potentiation) for each firing unit is described by the equation for Dn(t)
[pmol/kgBW] [17].
Each different firing unit n is then characterized by the same triple of equations (Bn(t),
Dn(t), Jn(t)), with different parameter values. As described in depth elsewhere [17], their values
are randomly sampled from given (usually lognormal) distributions.
The differential equation associated to Bn is:
dBnðtÞ
dt
¼   anBnðtÞ þ anGn þ ðRn   BnðtÞÞd w fGðtÞ < BnðtÞgð Þð Þ; ð5Þ
where αn [min
−1] is the rate of recovery of sensitivity of the secretory unit, G(t) [mM] is the
external glycemia sensed by all the secretory units (that is the glucose plasma concentration),
and δ(�) is a Dirac delta term specifying instantaneous increase of the threshold to the refrac-
tory level Rn, associated with discharge of insulin, at any time the glucose stimulus G(t) exceeds
the controller threshold Bn; χ is the characteristic function of its argument set.
The parameter Gn is the only one that is not extracted from a lognormal distribution, but
instead from a distribution with the following density (see for more details [17]):
f ðgÞ ¼ ngn
1=2
gn  1
gn þ gn1=2
� �2 ; ð6Þ
depending on the two parameters g1/2 [mM] and ν [#].
The Insulin Secretion Rate (ISR) is defined as:
ISRðtÞ ¼
XN
n¼1
JnðtÞdðwðfGðtÞ < BnðtÞgÞÞ; ð7Þ
where N is the total number of firing units. Basically, Eq (7) states that the ISR at time t is given
by the sum of the insulin packets fired by the units whose threshold Bn(t) is smaller than or
equal to the current glycemia G(t). Insulin then flows to the portal vein and the liver according
to:
dQðtÞ
dt
¼   hxQðtÞ þ ISRðtÞ ð8Þ
where Q [pmol/kgBW] refers to the insulin amount in the portal vein/liver compartment.
Then, insulin mass Q enters the plasma insulin distribution space according to the following
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equation:
dIðtÞ
dt
¼   k4IðtÞ þ
hdQðtÞ
VI
; ð9Þ
where I(t) [pM] is the serum insulin concentration. Finally, glucose plasma concentration is
described by:
dGðtÞ
dt
¼   k1~uðGðtÞÞ   k2IðtÞGðtÞ þ
k3ðtÞ
VG
: ð10Þ
where:
1. the first term in (10) describes approximately the (supra-threshold) driving glycemia for
urinary glucose elimination:
~uðGÞ ¼
0; G < Gu;
G   Gu; G � Gu:
(
ð11Þ
with k1 [/min] the apparent insulin-independent renal elimination rate for glucose, occur-
ring at glycemias greater than the threshold Gu [mM];
2. the second term is the insulin-dependent glucose uptake, with k2 [/min/pM] being the rate
of glucose uptake by tissues per pM of serum insulin concentration;
3. the third term k3(t) [mmol/kgBW/min] refers to the net balance between hepatic glucose
output and insulin-independent zero-order glucose tissue uptake (essentially by the brain),
with VG [L/kgBW] the apparent distribution volume for glucose.
In order to account for the noisy time-course of the last term k3, a stochastic model has
been employed:
k3ðtÞ ¼ �k3 þ ~sðxðtÞÞ; ð12Þ
where �k3 [mmol/kgBW/min] is a central value for k3(t) and ξ(t) [mmol/kgBW/min] is a sto-
chastic process. For further details, see [17].
Modifications of the two models
In the present work, we use the fact that the Compact Model [10] is able to fit IVGTT data of a
virtual patient generated by the extended model [17]. In a previous work [24] we obtained very
good fits of the Compact Model on the Extended Model using directly parameters reported in
[17] for generating virtual patients with profiles ranging from NGR to T2DM; nevertheless,
we introduce here some modifications of the Extended Model in order to better reproduce
observed IVGTTs from a larger sample of clinical tests.
In particular, since both the Extended and the Compact Model do not present any term of
insulin-independent glucose elimination, we modified the glycemia Eqs (1) and (10) respec-
tively as:
dGðtÞ
dt
¼   kXGIIðtÞGðtÞ þ
Tgh
Vg
  kXGGðtÞ ð13Þ
Consistency of compact and extended models of glucose-insulin homeostasis
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and
dGðtÞ
dt
¼   k1~uðGðtÞÞ   k2IðtÞGðtÞ þ
k3ðtÞ
VG
  kXGGðtÞ; ð14Þ
Consequently from (13), the new value for Tgh is computed at the equilibrium as:
Tgh ¼ ðkXGIIbGb þ kXGGbÞVG: ð15Þ
It is to be noted that the Compact Model does not include the glycosuria term, which is instead
present in the Extended Model—see Eq (10).
Virtual patient fitting
Before producing virtual patients with the Extended Model, some fine tuning of the model
parameters was thought to be advisable in order to better match glycemia and insulinemia
trends of Normal Glucose Regulation (NGR) patients undergoing an Intra-Venous Glucose
Tolerance Test (IVGTT), as reported in the literature (original data which served to set the
best parameters values derived from Panunzi et al. [10], from which only the subsample of
lean subjects was considered). A few modifications in the parameter/metaparameter values of
the Extended Model have therefore been carried out, as reported in Table 1: as it may be
noticed, the glucose net balance mean value (�k3) has been halved, while the mean value of the
rate of recovery of sensitivity of the secretory unit (αn) has been decreased, obtaining a slower
insulin dynamics. Moreover, the renal glucose elimination threshold Gu has been increased
according to the literature. In Fig 3 are reported as thin black lines the 5th and 95th percentile
of the data analyzed in [10], while the median of 100 virtual NGR patients generated by the
Extended Model with the new parameter values reported in Table 1 is shown as a thick red
line. This trend is coherent with NGR glycemia and insulinemia curves observed during
IVGTTs as reported in the literature [25–27].
With this new set of (meta-)parameters, virtual patients exhibiting different degrees of dis-
ease (ranging from a Normal Glucose Regulation (NGR) patient to a Type-2 Diabetes Mellitus
(T2DM) patient) were generated by modifying parameters as reported in Table 2. In the same
way as previously done [17], we obtained virtual T2DM patients by lowering peripheral insu-
lin-sensitivity (parameter k2), increasing liver glucose production �k3 (reflecting lower hepatic
insulin sensitivity), by lowering the size of the insulin packets (parameters μ(ρn) and mð�DnÞ),
and by lowering firing thresholds (whose distribution depends on the parameter g1/2). The
resulting pancreatic behavior still shows a higher insulin production given by the higher num-
ber of recruited firing units (due to lower firing thresholds), in the effort to compensate the
lower insulin sensitivity and under the hypothesis that these T2DM patients are still able to
compensate. However, the ability of these subjects to further increase their pancreatic insulin
secretion responding to higher glycemias is severely limited.
Table 1. Changed parameter values of the Extended Model with respect to [17].
Symbol Units Mean Std. deviation Value
αn min
−1 7.5 × 10−2 0.12 –
�k3 mmol/kgBW/min – – 5 × 10
−3
Gu mM – – 11
kXG min−1 – – 3 × 10−3
https://doi.org/10.1371/journal.pone.0211331.t001
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We generated IVGTT glycemia and insulinemia curves for a total of 500 virtual patients,
divided into 25 degrees of morbidity, ranging from “pure” NGR to “pure” T2DM condition in
25 uniform steps (see Table 3); this choice is a good tradeoff between the computational time
required to generate all the cohort and the value necessary to have an “average” patient for
Fig 3. Median of 100 virtual NGR patients generated by the Extended Model (red curves). The black curves
represent the 5th and 95th percentile of the data analyzed in [10].
https://doi.org/10.1371/journal.pone.0211331.g003
Table 2. Compact Model parameter estimates for a NGR, pre-diabetic and T2DM virtual patient (see Figs 4, 5 and
6).
Par. NGR Pre-diabetic T2DM
IΔ 49.8 38.592 31.03
τg 19.65 18.85 20.275
kXGI 1.19 × 10−4 7.04 × 10−5 3.66 × 10−5
kXI 7 × 10−2 7.4 × 10−2 5.5 × 10−2
γ 3.6473 5.2394 6.687
https://doi.org/10.1371/journal.pone.0211331.t002
Table 3. Parameters varying values for T2DM patient undergone an IVGTT.
Par. NGR T2DM
k2 1.4 × 10−4 0.1 × 10−4
�k3 0.005 0.005 × 1.6
μ(ρn) 6.5 × 10−3 6.5 × 10−3 � 0.05
mð�DnÞ 3 × 10
−3 3 × 10−3 � 0.3
g1/2 9.7697 4
https://doi.org/10.1371/journal.pone.0211331.t003
Consistency of compact and extended models of glucose-insulin homeostasis
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each class. For each degree of morbidity, 20 virtual patients were generated exhibiting some-
what different behavior due to the stochasticity intrinsic in the Extended Model (given by the
randomly generated structural parameters). Glycemia and insulinemia curves of T2DM
patients undergoing IVGTTs as reported in the literature [27–29] are comparable to the ones
generated by the Extended Model.
Observation data were then extracted for each virtual patient from the glycemia and insuli-
nemia curves at times −10, −5, −0.5, 2, 4, 6, 8, 10, 15, 20, 25, 30, 40, 50, 60, 90, 120 min. The
“observations” were finally fitted with the Compact Model, estimating the following vector of
parameters θ:
θ ¼ ID tg kXGI kXI g
  �T
: ð16Þ
Since the simulated glucose bolus has been set in such a way to produce a sudden glycemia
increment of 10 mM for every patient, GΔ in Eq (2) was fixed to 10 mM as well. The glucose
distribution volume VG was set to 0.2 L/kgBW and kept fixed during the generation of all vir-
tual patients.
The fit for each virtual patient was performed by solving a constrained optimization prob-
lem (lower and upper bounds were considered) using a Nelder-Mead algorithm minimizing
the following loss function λ:
l ¼
Gi   G^i
G^i
 !2
þ
Ii   I^ i
I^ i
 !2
; ð17Þ
where Gi and Ii are observed glycemia and insulinemia at time t = i, whereas G^i and I^ i are the
corresponding estimated glycemia and insulinemia. This function was adopted in order to
consider at the same time both glycemia and insulinemia data, using a normalization factor.
Results
Virtual NGR patients were generated by using the same model parameter values employed for
producing curves reported in Fig 3. Fig 4 reports the result of the fitting procedure on data
extracted from a virtual NGR patient, while Figs 5 and 6 report the fitting performance for a
virtual pre-diabetic patient and for a virtual T2DM patient respectively; Table 2 reports the
Compact Model estimated parameters compared with the generating Extended Model param-
eter values.
Since the insulin-sensitivity parameter is present in both models (kXGI for the Compact
Model and k2 for the Extended Model), we reported in the same plot (Fig 7) the relation
between the generating k2 parameter values and the corresponding estimated kXGI values: as it
is clear from the figure, the cloud of points lies mostly along the line kXGI = k2, showing that
the Compact Model [10] and the Extended Model are very consistent in particular for what
concerns insulin sensitivity.
Fig 8 reports the same relationship when renal glucose output was added to the Compact
Model. In this case the points lie wholly on the identity line.
Fig 9 shows the relationship between generating average HGO from the Extended Model
(�k3) and the corresponding Tgh parameter from the Compact Model. As can be seen there is a
systematic underestimation of net HGO by the Compact Model.
In Fig 10 we report in the same plot (estimated net HGO Tgh against the generating net
HGO �k3) when the Compact Model includes the glycosuria term. In Fig 10 we notice that the
cloud of points lies around the line Tgh ¼ �k3: it is clear that the underestimation by the original
version of the Compact Model depends on having neglected glycosuria.
Consistency of compact and extended models of glucose-insulin homeostasis
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We recall that the relationship between circulating glycemia and insulin secretion for each
virtual patient depends on the threshold distribution of the parameters Gn (see Eq (5)), ran-
domly extracted from the distribution f(g) in Eq (6). The shape of this function depends on the
pathophysiological condition of the virtual patient and therefore on the value of its g1/2 param-
eter (see Table 3).
We now define z 2 [0, 1] [#] to be a coefficient of pancreatic reserve, representing, for each
given subject, the fraction of total firing units able to react to an abrupt raising in glycemia
above the baseline. It can be computed as:
z ¼ 1  
Z Gb
0
f ðgÞdg ¼ 1  
Gnb
Gnb þ gn1=2
¼
gn
1=2
Gnb þ gn1=2
; ð18Þ
where Gb [mM] is the basal glycemia of the patient (before the injection of the glucose bolus),
ν = 2.5137 [#] (see [17]) is constant for all patients and g1/2 [mM] varies, passing from NGR to
T2DM, according to Table 3.
Fig 11 shows the relationship between pancreatic reserve z and estimated parameter γ from
Eq (3), for each simulated subject. The virtual patients portrayed in the figure are identified with
Fig 4. Observations extracted from a virtual NGR patient undergone an IVGTT (red dots). The black line represents the
Compact Model fitting.
https://doi.org/10.1371/journal.pone.0211331.g004
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a different colored marker depending on their estimated insulin sensitivity k^XGI [min
−1pM−1]:
healthy (k^XGI � 1� 10
  4, blue square), pre-diabetic (0:5� 10  4 � k^XGI < 1� 10
  4, red trian-
gle) and diabetic (k^XGI < 0:5� 10
  4, black dot). In this figure, healthy and pre-diabetic patients
cluster into two tight distinct sets; diabetic patients are scattered over a different, widely diffused
set. The three sets present a clear differentiation based on the value of the pancreatic reserve z:
healthy subjects exhibit a high pancreatic reserve ranging from 0.7 to 0.9, pre-diabetic patients
are characterized by a lower reserve value ranging from 0.4 to 0.8 and diabetic subjects present
with a very low index of pancreatic reserve, below 0.4. NGR and pre-diabetic patients exhibit
estimated values of γ which lie in the neighborhood of a falling parabola on the plane z-γ,
reported in Fig 11 as a blue curve, their γ increasing as the pancreatic reserve z decreases. The
diabetic patients, instead, although having low values of z, exhibit widely different estimated val-
ues for γ. The behavior of the z-γ relationship for normal and prediabetic subjects is clear. In the
case of diabetic patients, the actual pancreatic reserve is so low, and the maximal possible
increase in insulin secretion is so small, that the γ parameter from the Compact Model is diffi-
cult to identify precisely, with the corresponding worsening of the scatter of the estimates as z
goes to lower and lower values.
Fig 12 shows, for the 500 virtual patients, the relationship between the estimated γ and the
value of Tmaxig for the Compact Model, representing the maximum reachable Insulin Secretion
Fig 5. Observations extracted from a virtual prediabetic patient undergone an IVGTT (red dots). The black line
represents the Compact Model fitting.
https://doi.org/10.1371/journal.pone.0211331.g005
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Rate. The value Tmaxig has been computed as follows:
Tmaxig ¼ K^ xiIbVi
1þ
Gb
G�
  �g
Gb
G�
  �g ; ð19Þ
where K^ xi [min
−1] is the estimated constant disappearance rate for insulin, Ib is the basal insuli-
nemia of the patient, VI = 0.25 [L�kgBW−1] is the constant distribution volume for the virtual
patient (from the Extended Model) and G� = 9 [mM] is the glycemia at which the insulin secre-
tion rate is half of its maximum and is fixed for all patients. Both VI and G� values are the same
as in [10].
Also for Fig 11, when plotting Tmaxig against γ, the subjects cluster again in three well defined
groups: NGR patients (blue squares) exhibiting low values of γ, present a Tmaxig which is typi-
cally below 4 pmol/min/kgBW; pre-diabetic patients (red triangles) exhibit higher values of γ
and higher Tmaxig ; diabetic patients (black dots), showing values of γ in a wide range (due to the
above-mentioned difficulty of precisely estimating γ when increments of insulin secretion are
limited), present a Tmaxig above 3 [pmol/min/kgBW]. This pattern is consistent with the modest
needs for increased insulin secretion in healthy, insulin-sensitive subjects, in whom, on the
other hand, no ceiling for insulin secretion is readily apparent, hence the low nonlinearity
coefficient γ, and vice versa for insulin-resistant subjects.
Fig 13 reports the dependency of Tmaxig on z for each patient. We may observe the same clear
separation among the three different classes of patients apparent in the other plots.
Fig 6. Observations extracted from a virtual T2DM patient undergone an IVGTT (red dots). The black line
represents the Compact Model fitting.
https://doi.org/10.1371/journal.pone.0211331.g006
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It can be seen that NGR patients exhibit a high value of pancreatic reserve z and low values
of Tmaxig , since they do not need high insulin production due to their good insulin sensitivity;
conversely, pre-diabetic and diabetic patients, with a lower pancreatic reserve, have a higher
Tmaxig , since they need to compensate their lower insulin-sensitivity.
Discussion
In the past 50-60 years many attempts at mathematical modelling of different aspects of the
glucose-insulin system have been made. Some contributions concentrated more on the insulin
secretion mechanisms [15, 16, 30], others more with short-term modelling of perturbation
experiments [9, 10, 13, 14, 31], and some publications describe more complex models, from
multi-organ models [8, 32] to maximal models for in-silico Type 1 diabetes virtual patient sim-
ulation [33–37].
Our group has been active in this area for many years. We have addressed in particular total
body or organ-level integrated mechanisms, modelling both short-term experiments [10, 11,
13, 14, 18], pancreatic insulin release mechanisms based on firing units [15, 17, 24], long term
compensation and disease development [38], incretin effect [39].
Fig 7. Dependence of estimated insulin sensitivity kXGI (Compact Model) from generating insulin sensitivity k2
(Extended Model). Each dot represents a single virtual patient, while the line is the bisector kXGI = k2. Coefficient of
correlation and its associated P-value: r = 0.97 (P< 0.001).
https://doi.org/10.1371/journal.pone.0211331.g007
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Our overall goal is to eventually obtain a coherent suite of models addressing different rele-
vant clinical issues (e.g. IVGTT and OGTT for insulin sensitivity determination, or dynamics
of insulin secretion), suitable for integration into an overall scheme. These models should be
individually effective in dealing with the specific dynamics they approximate, should exhibit
appropriate qualitative behavior from a mathematical viewpoint, should have desirable statisti-
cal properties leading to a-posteriori parameter identifiability and should also be consistent
with one another, shedding light on the actual mechanisms involved in glucose homeostasis.
In particular, the clinical use of a compact, identifiable model should be justified by our
confidence that it does capture the basic relevant physiology, if not all possible features of
interest. In the present work we are trying to establish the relationship between an extended,
validated model (which by its very size cannot be fruitfully employed for the analysis of limited
experimental data e.g. from an IVGTT) and a Compact Model of proven effectiveness in esti-
mating insulin sensitivity from small datasets. By generating virtual patients from the
Extended Model and fitting them with the Compact Model we are able to link variations in the
(simulated) physiology with diagnostic parameter value changes.
Some modifications of the Extended Model parameter values (with respect to previously
published values [17]) were found to be necessary in order for simulated IVGTT curves to lie
Fig 8. Dependence of estimated insulin sensitivity kXGI (Compact Model, with glycosuria term) from generating
insulin sensitivity k2 (Extended Model). Each dot represents a single virtual patient, while the line is the bisector
kXGI = k2. Coefficient of correlation and its associated P-value: r = 0.98 (P< 0.001).
https://doi.org/10.1371/journal.pone.0211331.g008
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squarely within 90% confidence bounds obtained from sets of clinically recorded IVGTT’s
from NGR subjects. These minor changes in the parameter values, however, did not affect the
reproducibility of the diverse patterns generated from the whole array of experimental proce-
dures, such as the slow (ultradian) [19] and fast oscillations [21], and the entrainment phe-
nomenon due to sinusoidal glucose infusions [40], which were all re-checked with the
modified parameter set.
Moreover, in order to align the two models, an insulin-independent glucose elimination
term was introduced in the glycemia equation of the Extended Model. The insulin secretion
formalization remains, of course, radically different between the complex Extended and the
simple Compact Models.
Data of 19 patients from previous clinical studies [11] were used to build 90% confidence
envelopes of the observed glycemia and insulinemia time courses.
Fig 3 shows that for the set of chosen parameters the median of 100 virtual NGR patients
undergoing an IVGTT experiment lies within the 90% envelopes from real observations
highlighting the ability of the Extended Model to reproduce well real IVGTT data.
Starting from the NGR parameter values, progressive degrees of clinical worsening (up to
T2DM) were simulated by changing some model parameters, such as insulin sensitivity (k2),
average net hepatic glucose production (�k3), and other parameters related to the mechanisms
of insulin production (average ρn, average �Dn, and g1/2).
The Compact Model was then fitted onto the IVGTT data generated with the Extended
Model, and some of the Compact Model estimated parameters were compared with the corre-
sponding values of the generating parameters.
Fig 9. Dependence of estimated glucose net balance Tgh from the generating �k3 parameter. The red line represents
the bisector Tgh ¼ �k3. Coefficient of correlation and its associated P-value: r = 0.62 (P< 0.001).
https://doi.org/10.1371/journal.pone.0211331.g009
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Figs 4 to 6 clearly show the good performance of the Compact Model to fit the Extended
Model curves, highlighting its ability to reproduce both first and second phases of insulin
release. It is evident that as healthy conditions are altered to pre-diabetic and then to diabetic
status, the second phase of insulin release appears to be more and more prominent, probably
in order to compensate a higher insulin resistance translating into a lesser degree of glucose
uptake and persistently high plasma glucose concentrations.
The consistence and robustness of the Compact Model is evident from Fig 7 where the rela-
tionship between the two model parameters k2 (for the Extended Model) and kXGI (for the
Compact Model), both quantifying insulin sensitivity, approximates very well the identity line
in the k2-kXGI plane.
The overestimation of the insulin sensitivity index (k2) for very high insulin resistance
patients is due to the absence, in the Compact Model, of the term representing glucose renal
elimination, which is instead present in the Extended Model. While, in principle, this struc-
tural difference could be absorbed by a lower net HGO (Tgh), this compensation mechanism is
insufficient (Fig 9) as it is glucose-independent: this causes a higher glucose uptake, which in
the model is represented by a second order term (in glycemia and in insulinemia). Figs 8 and
10, compared with the corresponding Figs 7 and 9, show how the introduction of the glycos-
uria term in the Compact Model restores the linear relationship between kXGI and k2 even at
low insulin sensitivities, as well as solving the underestimation problem of Tgh with respect to
�k3 (the net HGO in the Extended Model).
Fig 10. Dependence of estimated glucose net balance Tgh (from the Compact Model comprehensive of the
glycosuria term) from the generating �k3 parameter. The red line represents the bisector T 0gh ¼ �k3. Coefficient of
correlation and its associated P-value: r = 0.68 (P< 0.001).
https://doi.org/10.1371/journal.pone.0211331.g010
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Fig 11. Dependence of estimated Compact Model parameter γ from proportion of pancreatic reserve z (extracted
from generating Extended Model data) for NGR (blue squares), pre-diabetic (red triangles) and T2DM (black
dots) patients.
https://doi.org/10.1371/journal.pone.0211331.g011
Fig 12. Dependence of Compact Model parameter Tmaxig (determined from estimated parameters) from estimated
Compact Model parameter γ for NGR (blue squares), pre-diabetic (red triangles) and T2DM (black dots) patients.
https://doi.org/10.1371/journal.pone.0211331.g012
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It is reassuring, while not surprising, that variations in insulin sensitivity (from 0.1 × 10−4
to 1.4 × 10−4) in the generating Extended Model are reliably captured by the Compact diagnos-
tic model. This supports the use of the Compact SDM model in clinical practice, lending credi-
bility to the measures obtained from it.
Of greater interest is however the observation portrayed in Fig 11. When pancreatic reserve
is maintained (z> 0.4, see Eq (18)), there is a clear (inverse) relationship between said pancre-
atic reserve and the nonlinear behavior of the pancreatic insulin release represented by param-
eter γ. When pancreatic reserve is exhausted, the increase in insulin secretion is too small with
respect to the increase in glycemia with resulting very variable values of the nonlinearity expo-
nent γ. Fig 13 shows that the maximum insulin production Tmaxig is small in athletes or very
healthy subjects (the pancreas in these subjects is not typically stimulated very much since
insulin sensitivity is excellent), increases with BMI and prediabetes (consistently with clinical
observations of high insulinemias in these subjects) and then decreases as the clinical picture
worsens and (relative) pancreatic insufficiency develops; again consistently with clinical
observations.
Conclusion
A refinement of our understanding of the population-of-controllers interpretation of the insu-
lin secretion behavior of the pancreas (in the several degrees of impairment between NGR and
T2DM) explains why the Compact Model for the IVGTT needs to explicitly incorporate the
Fig 13. Dependence of Compact Model parameter Tmaxig (determined from estimated parameters) from proportion
of pancreatic reserve z (extracted from generating Extended Model data) for NGR (blue squares), pre-diabetic
(red triangles) and T2DM (black dots) patients.
https://doi.org/10.1371/journal.pone.0211331.g013
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saturating nonlinearity of insulin secretion with increasing glycemia, and the fact that this
nonlinearity worsens with progressive worsening of the clinical picture.
This consistency in the behavior of the two models, developed for and fitted on very differ-
ent sets of data, increases our confidence that both models, each in its own domain, are reliable
representations of the actual physiology.
It is remarkable that the Compact Model, with only two parameters relative to the insulin
secretion mechanism, and estimable on the small datasets from IVGTT experiments, is able
to capture a series of detailed physiological mechanisms explicated and represented in the
Extended Model: the end-result of a very complex set of events, such as the potentiation and
synchronization of the whole β-cell population, along with the introduction of a heterogeneous
behaviour of the secretory units (from the distribution of thresholds to the distribution of the
rate of recovery of sensitivity) appears to be well captured by the very simple but specific non-
linear function of the Compact Model.
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